Home / Drug shortages / Lisdexamfetamine Dimesylate Capsule

Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Apotex Corp.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Apotex Corp. with status Current. The shortage was first posted on 11/01/2023. Reported reason: Delay in shipping of the drug

Shortage Details

Status
Current
Company
Apotex Corp.
Package NDC
60505-4743-1
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)
Initial Posting
11/01/2023
Revised Date

Reason

Delay in shipping of the drug

FDA data resources